It is thus possible that DIEXF amplification is a consequence of co-amplification with MDM4. When we analyzed the same breast cancer datasets, we observed that amplification of DIEXF and MDM4 significantly overlapped (P < 0.001, Figure 1C). The gene discussed is MDM4; the disease is breast carcinoma.